![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Saneca Pharma receives confirmation of multi-dosage cGMP approval for Russia
Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form...
Industry 4.0 from Bosch: a new level of efficiency Digital and virtual support facilitate...
At interpack 2017, Bosch Packaging Technology shows how industry 4.0 solutions provide higher efficiency in...
Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery...
Charles River Laboratories International, Inc. , a leading early-stage contract research organization announced that it...
Cellceutix Provides Update on Developing p53 Drug Candidate Kevetrin as an Oral Anti-Cancer Agent
Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory,...
Johnson Matthey and Rennovia announce licence agreement with ADM for glucaric acid production technology
Johnson Matthey, a global specialty chemicals company and provider of advanced process technologies, and Rennovia...
Aldevron expands manufacturing scale and implements single-use fermentation technology
Aldevron, a leading biotechnology contract manufacturing and development organization, is now using a 30-liter single-use...
Mundipharma, Helsinn Expand Licensing and Distribution Agreements for Leading Anti-emetic Products
Mundipharma and Helsinn Group have expanded their collaboration, signing amendments to licensing and distribution agreements...
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone)
AMAG Pharmaceuticals, Inc. and Endoceutics, Inc. announced that they have entered into an exclusive license...
Immune Pharmaceuticals Enters a Research Partnership to Develop Mono and Bispecific Antibodies
Immune Pharmaceuticals Inc , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Catalent To Develop Softgel Capsules For JOT’s Leading Orphan Disease Candidates
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for...